You have a defined model limitation
The team knows what is missing from the current experimental approach.
Work with us
De-risk the application before the purchase.
JetBio’s commercial pathway begins with fit, success criteria and evidence. It is designed for research teams that want a credible development partner, not a black-box equipment transaction.
The feasibility pathway
A defined next step at every stage.
The scope can be light or detailed, but the logic stays the same: qualify the need, define success, generate relevant evidence, then decide whether to progress.
- 01
Fit discussion
We review the biological question, current workflow, pain point and reason for considering bioprinting.
- 02
Feasibility brief
We define cells, materials, geometry, format, readout, constraints, responsibilities and decision criteria.
- 03
Scoped evaluation
A project tests the most important technical and workflow assumptions against agreed evidence gates.
- 04
Commercial review
The evidence is reviewed together. If the case is strong, we define the configuration, terms and implementation route.
- 05
Onboarding and development
The planned model includes installation, training, method transfer and application support appropriate to the agreed scope.
A good starting brief
Bring the question, not a finished specification.
We can make the first discussion more useful if you can share the application, cell types, materials, desired structure, experimental format and endpoint.
- The limitation in your current model
- The biological behaviour you need to reproduce
- The format and throughput your workflow requires
- The evidence that would justify a next step
Who this is for
High-fit research teams.
You can define a useful endpoint
There is a measurable result that would support a scientific or commercial decision.
You will co-develop responsibly
Your team can contribute materials, domain knowledge, feedback and time to the evaluation.
Start a useful conversation
Let’s decide whether JetBio fits.
A 20-minute first conversation can establish the scientific need, the likely print route and whether a feasibility brief is worthwhile.